| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10962873 | Vaccine | 2015 | 8 Pages | 
Abstract
												The economic burden of influenza in LMIC encompasses multiple dimensions such as direct costs to the health service and households, indirect costs due to productivity losses as well as broader detriments to the wider economy. Evidence from sub-Saharan Africa and in pregnant women remains very limited. Heterogeneity of methods used to estimate cost components makes data synthesis challenging. There is a strong need for standardizing research, data collection and evaluation methods for both direct and indirect cost components.
											Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Natasha de Francisco (Shapovalova), Morgane Donadel, Mark Jit, Raymond Hutubessy, 
											